Citadel Advisors
YTEN

Citadel Advisors’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Citadel Advisors’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-421
Closed -$2.42K – 15701
2023
Q4 		$2.42K Sell
421
-686
-62% -$4.56K ﹤0.01% 13701
2023
Q3 		$8.68K Buy
+1,107
New +$27.9K ﹤0.01% 13174
2022
Q3 		– Sell
-745
Closed -$40K – 13881
2022
Q2 		$40K Buy
+745
New +$52.6K ﹤0.01% 12069
2020
Q1 		– Sell
-175
Closed -$29K – 10349
2019
Q4 		$29K Buy
+175
New +$55.6K ﹤0.01% 8879
2019
Q2 		– Sell
-45
Closed -$49K – 10017
2019
Q1 		$49K Buy
45
+32
+246% +$34.4K ﹤0.01% 8827
2018
Q4 		$10K Sell
13
-17
-57% -$20.8K ﹤0.01% 8930
2018
Q3 		$40K Buy
+30
New +$40.8K ﹤0.01% 8852
2018
Q2 		– Sell
-17
Closed -$32K – 9405
2018
Q1 		$32K Buy
+17
New +$28.8K ﹤0.01% 8038
2017
Q2 		– Sell
-3
Closed -$11K – 8215
2017
Q1 		$11K Hold
3
– – ﹤0.01% 7335
2016
Q4 		$11K Buy
+3
New +$11.5K ﹤0.01% 7152
2016
Q2 		– Sell
-1
Closed -$20K – 7545
2016
Q1 		$20K Buy
+1
New +$14.8K ﹤0.01% 6464
2015
Q2 		– Hold
0
– -$15K – 9174
2015
Q1 		– Hold
0
– – – 8072
2014
Q4 		– Hold
0
– -$11K – 8798
2014
Q3 		– Hold
0
– – – 7734
2014
Q2 		– Sell
-1
Closed -$38K – 8388
2014
Q1 		$38K Buy
+1
New +$79.2K ﹤0.01% 6945
2013
Q4 		– Hold
0
– – – 6628

Other funds holding YTEN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GWM
Grand Wealth Management Grand Rapids, Michigan $212M AUM 18.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's YTEN Position: Q1 2024 in Review

Citadel Advisors sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 421 shares — an estimated $2.42K sold.

Citadel Advisors first reported a position in YTEN in Q1 2014 and held it in 12 quarters. The position peaked at $49K in Q1 2019. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

  • Citadel Advisors reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 421 Yield10 Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $2.42K.
  • Citadel Advisors first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2014 and held it in 12 quarters.
  • Citadel Advisors's Yield10 Bioscience, Inc. Common Stock position peaked at $49K in Q1 2019.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.